Cargando…
miR‐132 mediates a metabolic shift in prostate cancer cells by targeting Glut1
Prostate cancer is the second leading cause of cancer‐related deaths among men worldwide. Early diagnosis increases survival rates in patients but the survival rate has remained relatively poor over the past years. Increasing evidence shows that altered metabolism is a critical hallmark in prostate...
Autores principales: | Qu, Wei, Ding, Shi‐mei, Cao, Gang, Wang, She‐jiao, Zheng, Xiang‐hong, Li, Guo‐hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4932453/ https://www.ncbi.nlm.nih.gov/pubmed/27398313 http://dx.doi.org/10.1002/2211-5463.12086 |
Ejemplares similares
-
MiR-378a inhibits glucose metabolism by suppressing GLUT1 in prostate cancer
por: Cannistraci, A., et al.
Publicado: (2022) -
Mir-1, miR-122, miR-132, and miR-133 Are Related to Subclinical Aortic Atherosclerosis Associated with Metabolic Syndrome
por: Šatrauskienė, Agnė, et al.
Publicado: (2021) -
Advances in Roles of miR-132 in the Nervous System
por: Qian, Yun, et al.
Publicado: (2017) -
A role for miR-132 in learned safety
por: Ronovsky, Marianne, et al.
Publicado: (2019) -
miR-328 mediates a metabolic shift in colon cancer cells by targeting SLC2A1/GLUT1
por: Santasusagna, S., et al.
Publicado: (2018)